143 related articles for article (PubMed ID: 30867747)
1. Silencing of the long non-coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial-mesenchymal transition.
Xie W; Liu X; Chen Q; Ma M; Yang X; Gong B; Sun T; Chen J
Oncol Lett; 2019 Mar; 17(3):3173-3180. PubMed ID: 30867747
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Long Noncoding RNA GHET1 Inhibits Cell Proliferation and Invasion of Colorectal Cancer.
Zhou J; Li X; Wu M; Lin C; Guo Y; Tian B
Oncol Res; 2016; 23(6):303-9. PubMed ID: 27131316
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA gastric carcinoma highly expressed transcript 1 promotes cell proliferation and invasion in human head and neck cancer.
Liu H; Wu Y
Oncol Lett; 2018 May; 15(5):6941-6946. PubMed ID: 29725422
[TBL] [Abstract][Full Text] [Related]
6. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT.
Liu H; Zhen Q; Fan Y
Int J Biol Markers; 2017 Oct; 32(4):e403-e408. PubMed ID: 28983895
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
[TBL] [Abstract][Full Text] [Related]
8. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer.
Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA GHET1 promotes thyroid cancer cell proliferation and invasion.
Liu Y; Shi P; Fang H; Zhao Z; Yang F; Zhang J; Jing S; Geng C
Transl Cancer Res; 2021 Sep; 10(9):4148-4157. PubMed ID: 35116711
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GHET1/miR-105/RAP2B axis regulates the progression of acute myeloid leukemia.
Xiao Y; Li T; Xue Q; Miao L
J Cancer; 2020; 11(23):7081-7090. PubMed ID: 33123297
[No Abstract] [Full Text] [Related]
13. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
[TBL] [Abstract][Full Text] [Related]
14. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
[TBL] [Abstract][Full Text] [Related]
15. LncRNA GHET1 activated by H3K27 acetylation promotes cell tumorigenesis through regulating ATF1 in hepatocellular carcinoma.
Ding G; Li W; Liu J; Zeng Y; Mao C; Kang Y; Shang J
Biomed Pharmacother; 2017 Oct; 94():326-331. PubMed ID: 28772210
[TBL] [Abstract][Full Text] [Related]
16. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
17. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA GHET1 promotes viability, migration and invasion of glioma cell line U251 by down-regulation of miR-216a.
Cao W; Liu B; Ma H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1591-1599. PubMed ID: 30840282
[TBL] [Abstract][Full Text] [Related]
19. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
Zhang Q; Zhang Y; Wang Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
[TBL] [Abstract][Full Text] [Related]
20. NDNF inhibits the migration and invasion of human renal cancer cells through epithelial-mesenchymal transition.
Xia L; Li S; Liu Y; Huang Y; Ni B; Wan L; Mei H; Li X; Cai Z; Li Z
Oncol Lett; 2019 Mar; 17(3):2969-2975. PubMed ID: 30867731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
